Novartis AG Newsroom

Goldman Sachs Remains a Hold on Novartis AG (NOVN)

TipRanksSep 18 17:30

Novartis AG: Hold Rating Justified Amid Kisqali's Market Potential and FDA Approval

TipRanksSep 18 15:58

Buy Rating Affirmed: Novartis AG's Strong Growth Outlook and Underestimated Pipeline Potential

TipRanksSep 14 20:49

Novartis AG (NOVN) Receives a Buy From UBS

TipRanksSep 11 23:55

Novartis Lower as BofA Downgrades on Risks to Valuation

Seeking AlphaSep 11 20:09

Novartis Analyst Ratings

BenzingaSep 11 18:30

B of A Securities Downgrades Novartis to Neutral, Lowers Price Target to $130

BenzingaSep 11 18:30

BofA Securities Downgrades Novartis AG(NVS.US) to Hold Rating, Raises Target Price to $130

Futu NewsSep 11 17:32

BMO Capital Maintains Novartis AG(NVS.US) With Hold Rating, Maintains Target Price $118

Futu NewsSep 6 19:31

Erste Group Maintains Novartis AG(NVS.US) With Buy Rating

Futu NewsSep 5 21:31

Novartis Analyst Ratings

BenzingaSep 5 18:50

Goldman Sachs Downgrades Novartis to Neutral, Raises Price Target to $121

BenzingaSep 5 18:50

Goldman Sachs Downgrades Novartis AG(NVS.US) to Hold Rating, Raises Target Price to $121

Futu NewsSep 5 17:33

Novartis Target Cut to $105 From $110 by Jefferies

Dow JonesSep 3 15:21

Novartis Cut to Hold From Buy by Jefferies

Dow JonesSep 3 15:21

Jefferies Downgrades Novartis AG(NVS.US) to Hold Rating, Raises Target Price to $123.5

Futu NewsSep 3 09:31

Novartis AG (NOVN) Receives a Buy From Kepler Capital

TipRanksAug 30 09:39

The latest pharmaceutical industry rating by S&P reveals that Johnson & Johnson (JNJ.US) and Roche (RHHBY.US) are ranked at the top for superior financial and innovative abilities.

Zhitong FinanceAug 19 11:30

Hold Rating on Novartis AG: Cautious Optimism for Fabhalta Amidst FDA Approval and Market Potential

TipRanksAug 8 22:47

Berenberg Raises Price Target on Novartis to CHF86 From CHF77, Maintains Hold Rating

MT NewswiresJul 23 19:09